Summary
Introduction
Peripheral tissues, skeletal muscle in particular, are considered to be major sites for the transamination of the branched-chain amino acids (BCAA), leucine, valine and isoleucine [l, 21. Branched-chain 2-0x0 acids (BCOA), however, may either be oxidized in muscle, as indicated by experiments in vitro [3,4], or be released into the circulation for removal by the liver, as shown in the rat hind limb in vivo 151. Whether human limb tissues also release BCOA into the circulation is investigated here together with the relationship between plasma BCAA and BCOA concentrations in several conditions (diabetes, starvation, cirrhosis and muscular dystrophy) known to be associated with altered metabolism of BCAA [61.
Increased metabolism of BCAA by rat muscle in vitro is associated with increased release of alanine [7-9] and glutamine [10-11]. Alanine and glutamine are quantitatively the most important amino group carriers leaving the human forelimb in vivo [ 121, and a leucine meal has been shown to increase glutamine and total nitrogen release from forearm muscle 1131. There is, however, still doubt about which of these amino acids is quantitatively the more important amino group carrier leaving the human forelimb in vivo under conditions of increased BCAA utilization. Therefore we have measured the arteriovenous concentration differences of various amino acids across the human forelimb after giving a protein meal and intravenous leucine to normal man.
Measurement of glutamine concentrations with a reliable sensitive enzymatic method soon after obtaining samples is particularly important for this work. Estimations with an amino acid analyser can be unsatisfactory since glutamine may not separate from other amino acids, as in the study of Wahren et al. [141, and because glutamine degrades spontaneously during storage in frozen solution [151 and during passage through the hot column of an analyser.
Methods

Experimental subjects
Experiments on the ingestion of steak and the infusion of leucine were started between 08.00 and 09.00 hours on four overnight-rested and fasted normal male subjects (age 30 f 8 years, weight 69 f 2 kg, height 174 f 2 cm; mean values f SEM), who had previously been on normal diets.
Plasma for the determination of antecubital venous branched-chain amino and 2-0x0 acids in patients with a variety of clinical conditions ( Fig.  1) was taken between 07.30 and 09.00 hours from overnight-rested subjects who had also fasted either overnight or longer (starved subjects). The 13 normal subjects (1 1 males, two females, age 29 f 3 years, weight 69 f 2 kg, height 174 f 1 cm) had previously been on normal diets which were estimated to supply about 100 g of protein/day. The seven cirrhotic patients (two males, five females, age 50 2 years, weight 59 f 5 kg, height 171 f 3 cm: four alcoholic cirrhosis, two primary biliary cirrhosis, one chronic active hepatitis on 10 mg of prednisolone/day), all had well compensated liver disease with a mean plasma albumin of 35 g/l, and had previously been on hospital diets which supplied 40-60 g of proteidday. The four muscular dystrophy patients (three males, one female, age 21 f 5 years, weight 47 f 12 kg, height 154 ? 9 cm: two Duchenne muscular dystrophy with one judged histologically to be pseudohypertrophic, one facioscapulohumeral muscular dystrophy, one of unknown cause) had previously been on hospital diets which supplied 60-80 g of proteidday and all had evidence of some muscular atrophy. The nine insulin-dependent diabetic subjects, in addition to overnight resting and fasting, had plasma sampled before receiving morning insulin; these subjects (seven males, two females, age 42 f 6 years, weight 65 f 4 kg, height 172 k 2 cm) had previously been on a variable carbohydrate hospital diet supplying approximately 100 g of proteidday. The four subjects who starved for 2 and 4 days (four males, age 30 f 2 years, weight 76 kg, height 172 f 2 cm) had previously been on normal diets estimated to supply approximately 100 g of protein/day and returned to similar diets on day 5 after the start of the 4 day fast. Leucine infusions were performed in four subjects from four of the above groups: cirrhosis, diabetes, muscular dystrophy and starvation (before and on day 4 of starvation). These 16 individuals had only venous blood withdrawn, for analysis of plasma BCAA and BCOA concentrations, and were included in a previous study [61 which gives their individual details.
Procedures
Analysis of blood metabolites. Blood samples (or plasma prepared immediately after sampling) were deproteinized with 2 vol. of 10% (w/v) perchloric acid. After removal of the protein precipitate, the extracts were neutralized with 20% (w/v) KOH, then either kept on ice or stored at -2OOC until analysed. The concentrations of BCOA (sum of 4-methyl-2-oxovalerate, 3-methyl-2-oxobutyrate and 3-methyl-2-oxovalerate) were determined by using leucine dehydrogenase purified from Bacillus subtilis and corrected, in the case of blood, for a 77% recovery [51. D-Glucose, L-lactate, pyruvate, acetoacetate and D-3-hydroxybutyrate were determined by methods described elsewhere [ 161. L-Alanine was determined with L-alanine dehydrogenase [ Experiments with radiolabelled substrates. The proportion of plasma to whole blood volume was determined with inulin [l-14Clcarboxylic acid, a marker of the extracellular space. The distribution of BCOA in blood was determined in two ways: enzymatic assay of whole blood and plasma BCOA and recovery in plasma of the tracer 4-methyl-2-oxo[ l-14Clvalerate, prepared from ~-[l-~~Clleucine 1221, after mixing with whole blood. The radiochemicals were from The Radiochemical Centre, Amersham, Bucks, U.K.
Arteriovenous concentration dverence measurements. Samples of blood were removed simultaneously from the brachial artery (A) and the antecubital vein (V). These samples were withdrawn via flexible lines connected to Teflon catheters fixed in position for 30 rnin before the first basal samples were taken. The venous catheters were directed for 3 4 cm into the deep vein with intent to increase the contribution of blood draining muscle. The hand was not occluded during arteriovenous blood sampling. Blood was also sampled simultaneously, for comparison, from a superficial mid-forearm vein (SV) via a flexible connection to a venous needle.
A and V blood samples were taken in duplicate, SV samples singly and basal samples were taken at two different times. Only whole blood was used for A-V difference measurements. Blood flow rates were not measured; previous studies have not demonstrated any significant change in forearm blood flow after ingestion of steak or administration of leucine [13, 14, 231 .
Protein meal. Grilled lean beef steak (250 g raw weight) was ingested, over a period of 10-12 min, starting at time 0 min. Arterial and venous blood samples were taken in duplicate simultaneously to obtain basal samples at -30 and 0 min, and thereafter at 30 min intervals for the next 3 h. All blood samples (3 ml each) were deproteinized immediately. Arterial plasma for insulin determination was also taken at these times. Infusion of leucine. L-Leucine [British Drug Houses Ltd; 3.8 g (29 mmol) dissolved in 200 ml of sodium chloride solution, 154 mmolh (saline)] was infused over a period of 8-10 min into the antecubital vein starting at time 0 min. Arterial and venous blood samples were taken simultaneously in duplicates at both -15 and 0 rnin to obtain eight basal samples from each subject and thereafter in duplicate at + 15, +30 and +60 min.
Plasma for insulin determination was also obtained at these times.
Ambient temperature. All experiments involv-
ing protein meals and leucine infusions were performed at ambient temperatures of 19-21 OC; skin temperatures were not measured. Venous plasma from patients with a variety of clinical conditions ( Fig. 1 ) was taken at hospital ward temperatures of approx. 2OoC, though temperatures were not measured on all occasions.
Statistics. Data were anlysed by using the Students t-test, which was applied to paired observations where possible.
Results
Distribution of BCOA in blood
The basal concentration of BCOA in forearm venous plasma was 69 & 4 pmolh (mean f SEM) and that in venous whole blood was 43 f 3 pmol/l. Plasma accounted for 60.7 & 1.0% of the whole blood volume, so that 97% of the BCOA present in the whole blood was accounted for by In patients with liver disease the venous plasma concentrations of both BCAA and BCOA were decreased significantly, but in the muscular dystrophy patients these values were not significantly different from normal. The venous plasma concentrations of BCAA and BCOA in the diabetic patients were somewhat variable. When these patients were arbitrarily divided into two groups, on the basis of their fasting blood glucose being less or greater than 10 mmol/l, the group with the higher blood glucose (14.9 f 1.0 mmol/l, mean f SEM, n = 4) showed significantly elevated concentrations of both BCAA and BCOA (593 48 and 97 f 9 ,umol/l respectively), while those with the lower, more normal blood glucose (7.1 f 1.0 mmol/l, n = 5) showed concentrations of BCAA and BCOA (429 f 45 and 59 f 5 pmol/l respectively) not significantly different from normal.
The close relationship (correlation coefficient, r = 0.989) between the venous plasma concentrations of BCAA and BCOA as seen in the post-absorptive subjects in the various clinical conditions (Fig. 1) was not observed after leucine infusion or after protein feeding (see below). In normal subjects given leucine there were large increases in the circulating concentrations of both plasma and whole blood BCAA (due almost entirely to leucine; Table l), and BCOA (Table  2 ). Similar changes in plasma BCAA and BCOA were observed after infusion of leucine into the cirrhotic and insulin-dependent diabetic subjects and the normal subjects after 4 days of starvation (data not shown; see reference 161). In the muscular dystrophy patients the increments in BCAA concentrations were somewhat greater than in the other groups of subjects, owing to the TABLE 1. Arterial (A) and arteriovenous (A-V) concentrations of amino acids in blood across the forelimb of four normal subjects given intravenous leucine L-Leucine (3.8 g) was infused between 0 and 10 min. Values (in pmol/l, or munits/l for insulin) are means k 1 SEM (four subjects). Results significantly different from the mean of pre-infusion (basal) measurements (four subjects): *P < 0.05; **P < 0.01. small body weight and leucine distribution volume [61. However, in all the subjects given leucine, the fractional rise in BCAA concentration was greater than that for BCOA so that at 15 and 30 min after the start of the leucine infusion the BCAAIBCOA concentration ratio increased by approximately 40% and returned towards normal values by 60 min (Fig. 2) .
Time after Concentrations
Effects of ingested steak and infused leucine on the circulating insulin and amino acid concentrations
After ingestion of steak there were significant increases in the arterial concentrations of all the measured amino acids except aspartate, tryptophan and taurine (Table 3 ). The BCAA were amongst those showing the largest rise (leucine, 256%; isoleucine, 256%; valine, 182% of basal values). The changes were accompanied by a twoto three-fold rise in the plasma insulin concentration (Table 3 ) and the substantial change in the A-V values would suggest a temporary change in amino acid exchange from net release to net uptake (Fig. 3) .
By contrast, leucine administration was followed by significant increases in the arterial concentrations of only leucine and glutamine (Table 1) . This was also associated with a twofold rise in plasma insulin concentration (Table 1) .
BCAA and BCOA exchange
Although the arterial concentration of BCAA doubled after ingestion of steak, the concentration of BCOA increased by less than 20% (Table 2) . BCAA accounted for 50% of those amino acids with a positive A-V between 1 and 2 h (Fig. 3) . At the same time there was only a small significant increase in the negative A-V for BCOA from a basal value of -1.9 pmolll to a value of -5 a 9 pmol/l at 2 h (Table 2) . In normal subjects leucine administration was followed by a large positive A-V for leucine (Table l) , but, as after ingestion of steak, the negative A-V for BCOA increased only slightly ( Table 2) .
The above effects were observed in all subjects.
Forelimb amino acid exchange
In the basal state alanine and glutamine together accounted for more than 50% of those amino acids with a negative A-V (Tables 1 and  3 ). After ingestion of steak the negative A-V for alanine decreased by 90% of the basal value (Table 3) , a directional change shared by most other amino acids (Table 3) . In marked contrast, the negative A-V for glutamine was unchanged, so that by 2 h after ingestion of the steak, glutamine accounted for approximately 75% of those amino acids with a negative A-V (Fig. 3) . After administration of leucine the A-V for alanine, and for most other amino acids, was not significantly altered (Table 1) . Glutamine again did not follow this pattern; its negative A-V doubled and its blood concentration increased significantly (Table 1) .
Eflects of ingested steak and leucine administration on intermediary metabolism
After administration of leucine to the normal subjects, their mean arterial blood glucose concentration decreased significantly (P < 0.01) from 5.18 f 0.14 in the basal state to 4.87 f 0.11 and 4-85 f 0.11 mmol/l (mean f S E M ,~ = 4) at 30 and 60 min respectively. The A-V for glucose also showed decreases at these times when compared with the basal values, from +0.19 f 0.04 to +0.10 f 0.03 (P < 0.05) and +0.15 f 0.05 mmol/l (not significantly different) respectively. By contrast, over the 3 h period after ingestion of the steak, no significant effects were observed on either the arterial concentration or the A-V value for glucose (data not shown).
Both arterial lactate and arterial pyruvate concentrations were elevated (P < Administration of leucine significantly (P < 0.01) elevated arterial ketone body concentrations from a basal value of 0.27 f 0.07 to a maximal value at 30 min of 0.44 f 0.08 mmol/l, due mostly to more acetoacetate. This was associated with a small, though not statistically significant, rise in the positive A-V value for ketone bodies. By contrast, ingested steak decreased circulating ketone body concentrations from a basal arterial valueof0.17 f 0.03 to 0.10 f 0.07 mmol/l at 90 min and this was associated with a maximal depression in the A-V value for ketone bodies from a basal value of +0.033 f 0.010 to +0.013 f 0.008 mmol/l (P < 0.05).
Contribution of muscle and superficial tissues to the forelimb arteriovenous direrence measurements
Since the present studies were undertaken without using a wrist cuff the arteriovenous measurements represent exchanges of metabolites with both the forearm and the hand, and will therefore have some contribution from both muscle and superficial tissues. Concurrent measurements were made of arterial-superficial forearm vein (A-SV) metabolite concentrations and the results (not shown) indicated that the presently reported exchange measurements reflect mostly muscle metabolism. This is because the effects of steak ingestion and leucine administration on all the A-SV values were either similar in direction to the reported A-V values but smaller in extent or not significantly different from basal A S V values.
Discussion
BCAA are found in both plasma and erythrocytes [24, 251. In man we find BCOA to be located almost entirely in plasma. This differs from observations on rat blood, showing association of BCOA with erythrocytes [26, 271, although the distribution of BCOA in human blood appears similar to that in bovine blood [261. Thus in humans variations in packed cell volume may appreciably affect the whole-blood concentration of BCOA. Hence, plasma measurements are used to compare circulating BCOA concentrations in various groups of patients and whole-blood measurements are used to assess sequential changes in BCOA concentrations and A-V differences.
Whole-body BCAA metabolism
The strong correlation between venous plasma BCAA and BCOA concentrations (Fig. 1) suggests that these metabolites are closely linked by an equilibrium reaction catalysed by the BCAA transaminases, enzymes which are distributed widely in human tissues [281. Only in the rested and fasted subjects and patients is the BCAA/BCOA ratio constant. Protein feeding (Fig. I ), leucine infusion (Fig. 2) and exercise [291 each increase the BCAA/BCOA ratio.
It was shown previously [61 that leucine clearance rates are decreased in starvation, muscular dystrophy and insulin-dependent diabetes and increased in cirrhosis. However, the plasma BCAA/BCOA ratio remained similar in all these subjects both before (Fig. 1) and after ( Fig. 2) being challenged with leucine. Hence changes in leucine transport into cells or transamination are unlikely to account for the varied rates of leucine clearance in these clinical conditions. Regulation by phosphorylation at the BCOA dehydrogenase complex seems more likely [301.
Branched-chain amino acid oxidation in limb tissues
The apparent increase in BCAA uptake by the forelimb tissues of normal human subjects after ingestion of steak (as judged by changes in the A-V values) is associated with only minor changes in the A-V for BCOA ( Table 2) . At this time, either BCAA is poorly metabolized by the forelimb tissues or any BCOA produced is preferentially oxidized rather than released. It is probable that BCAA catabolism does occur since, as judged by the A-V values (Table 3) , these amino acids contribute to approximately 50% of the amino acids entering the limb tissues after ingestion of steak (Fig. 3) In an attempt to further increase the rate of BCAA catabolism and to increase the release of BCOA by human forelimb, we challenged our subjects with a leucine load since similar experiments in the rat showed considerable increases in BCOA release by hindlimb tissues after leucine administration 1341. Administration of leucine to man as in the present study produces a massive increase in the positive A-V for leucine which, in part (see below), can be explained by a substantial uptake and catabolism of leucine by the forelimb, but little change in the negative A-V for BCOA ( Table 2) Evidence for leucine catabolism in the human forelimb after its administration as in the present study is largely circumstantial. Protein synthesis cannot account for a large uptake of leucine and an accumulation of this amino acid within the tissue would lead to its catabolism at an increased rate through mass action 121, more especially as the pool size for leucine in muscle is small [361. The increase in the negative A-V for glutamine subsequent to leucine administration (Table I) is consistent with this conclusion.
Our results ( Table 2 ) suggest either that the BCAA, and leucine in particular, are not readily catabolized in the tissues of the human forelimb or, more likely, that BCOA arising during their catabolism are oxidized rather than released into the circulation for further metabolism in other tissues. In either case other tissues must contribute to the elevation of the BCOA concentration in the circulation after leucine administration. Our results also cast some doubt about the source of circulating BCOA during the basal state in man since the A-V measurements suggest that basal release of BCOA by the forelimb tissues is small, whereas the capability for BCOA removal from the circulation seems large, as judged by the rapid decrease in their circulating concentration 15 min after leucine administration ( Table 2) . The situation appears different in the rat where muscle contributes large amounts of BCOA to the circulation for removal by the liver [ 51.
Nitrogen metabolism in the limb tissues
BCAA are effective stimulators of both alanine and glutamine release by rat muscle in uitro (for references see the Introduction). Our results would indicate glutamine rather than alanine to be the major vehicle by which nitrogen leaves human forelimb tissues in uivo after both a protein meal and an intravenous leucine load. These observations are for man previously in the overnight rested and fasted state and we cannot extrapolate these findings to other metabolic conditions. After ingestion of the protein meal we suggest glutamine contributes up to 75% of the total amino acid or 87% of the total amino acid nitrogen release by the forelimb tissues and that glutamine, not alanine, is synthesized de nouo after the intravenous leucine. The latter finding agrees with that of Aoki et al. [131, who showed elevated glutamine release after a leucine meal in man. However, the theoretical possibility that the elevated plasma leucine displaces intracellular glutamine into the circulation cannot yet be ruled out.
Selection of respiratory fuel
The decrease in the positive A-V for glucose by the forelimb in our overnight rested and fasted subjects in response to leucine in the present study is consistent with Sherwin's finding 1371, using radiolabelled glucose, of a decrease in peripheral glucose utilization in starving human subjects given leucine. We suggest further preservation of glucose carbon by an inhibition or inactivation of pyruvate dehydrogenase; this is suggested by an increase in the ratio for the negative A-V of 'glycolytic products' lactate, pyruvate and alanine (and possibly glutamine) to the positive A-V for glucose (see reference 1381 for a detailed support of this argument) and finds support from experiments in uitro on the inhibition of pyruvate dehydrogenase flux by leucine or its metabolites 1391. By contrast, this ratio is decreased after feeding with protein, which suggests either decreased formation of 'glycolytic products' by diversion of glucose carbon to glycogen or their increased removal by oxidation at the pyruvate dehydrogenase complex, or both. An increased oxidation of pyruvate would be consistent with the associated decrease in the positive A-V for ketone bodies 1381 and would imply net loss of glucose carbon for oxidation in the forelimb tissues.
